Skip to content
October 17, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Paradigm Health Unveils eSource Casebook: Revolutionizing Clinical Trial Data Capture for Enhanced Efficiency and Accuracy paradigm-health-unveils-esource-casebook-revolutionizing-clinical-trial-data-capture-for-enhanced-efficiency-and-accuracy
  • Medical Research and Clinical Trials

Paradigm Health Unveils eSource Casebook: Revolutionizing Clinical Trial Data Capture for Enhanced Efficiency and Accuracy

Evan Lee Salim May 9, 2026 0
London, UK – May 8, 2026 – In an era where clinical trial complexity is escalating, placing...
Read More Read more about Paradigm Health Unveils eSource Casebook: Revolutionizing Clinical Trial Data Capture for Enhanced Efficiency and Accuracy
Critical Review Challenges Meta-Analysis on Postoperative Radiotherapy for Early-Stage Oral Cancer with Perineural Invasion critical-review-challenges-meta-analysis-on-postoperative-radiotherapy-for-early-stage-oral-cancer-with-perineural-invasion
  • Medical Research and Clinical Trials

Critical Review Challenges Meta-Analysis on Postoperative Radiotherapy for Early-Stage Oral Cancer with Perineural Invasion

Nila Kartika Wati May 9, 2026 0
Bangalore, India – May 15, 2026 – A recent commentary published in the journal Cancers has raised...
Read More Read more about Critical Review Challenges Meta-Analysis on Postoperative Radiotherapy for Early-Stage Oral Cancer with Perineural Invasion
Unlocking the Hemostatic Paradox: How TFPI Levels Drive Coagulation Shifts in Pediatric IBD unlocking-the-hemostatic-paradox-how-tfpi-levels-drive-coagulation-shifts-in-pediatric-ibd
  • Chemotherapy and Targeted Therapy

Unlocking the Hemostatic Paradox: How TFPI Levels Drive Coagulation Shifts in Pediatric IBD

Ali Ikhwan May 9, 2026 0
In the complex landscape of pediatric medicine, few conditions present as many systemic challenges as Inflammatory Bowel...
Read More Read more about Unlocking the Hemostatic Paradox: How TFPI Levels Drive Coagulation Shifts in Pediatric IBD
A Five-Year Medical Mystery: Unraveling the Enigma of Coats-Plus Syndrome a-five-year-medical-mystery-unraveling-the-enigma-of-coats-plus-syndrome
  • Clinical Radiology and Imaging

A Five-Year Medical Mystery: Unraveling the Enigma of Coats-Plus Syndrome

Laily UPN May 9, 2026 0
For five years, a young patient lived in a diagnostic limbo, her life defined by mysterious brain...
Read More Read more about A Five-Year Medical Mystery: Unraveling the Enigma of Coats-Plus Syndrome
Sarepta Therapeutics at a Crossroads: Beyond Elevidys and the Pivot to RNA Innovation sarepta-therapeutics-at-a-crossroads-beyond-elevidys-and-the-pivot-to-rna-innovation
  • Treatment Innovations

Sarepta Therapeutics at a Crossroads: Beyond Elevidys and the Pivot to RNA Innovation

Muslim May 9, 2026 0
By Industry Analysis Desk Published May 7, 2026 In the high-stakes world of biotechnology, few companies have...
Read More Read more about Sarepta Therapeutics at a Crossroads: Beyond Elevidys and the Pivot to RNA Innovation
A Breakthrough in Supportive Care: Rezafungin Shows Promise for Preventing Fungal Infections in Stem Cell Transplant Recipients a-breakthrough-in-supportive-care-rezafungin-shows-promise-for-preventing-fungal-infections-in-stem-cell-transplant-recipients
  • Clinical Oncology Education

A Breakthrough in Supportive Care: Rezafungin Shows Promise for Preventing Fungal Infections in Stem Cell Transplant Recipients

Reynand Wu May 9, 2026 0
Main Facts: A New Frontier in Antifungal Prophylaxis For patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT)—a...
Read More Read more about A Breakthrough in Supportive Care: Rezafungin Shows Promise for Preventing Fungal Infections in Stem Cell Transplant Recipients
Recalculating: Navigating the Uncharted Territory of a Cancer Diagnosis recalculating-navigating-the-uncharted-territory-of-a-cancer-diagnosis
  • Survivorship and Post-Treatment

Recalculating: Navigating the Uncharted Territory of a Cancer Diagnosis

Layla Zulfa May 9, 2026 0
By Investigative Health Desk April 16, 2026 The journey through a cancer diagnosis is rarely a straight...
Read More Read more about Recalculating: Navigating the Uncharted Territory of a Cancer Diagnosis
Beyond the Plate: How Shanti’s ‘Meals Heal’ Program is Confronting the Epidemic of Loneliness beyond-the-plate-how-shantis-meals-heal-program-is-confronting-the-epidemic-of-loneliness
  • Integrative Oncology and Holistic Care

Beyond the Plate: How Shanti’s ‘Meals Heal’ Program is Confronting the Epidemic of Loneliness

Layla Zulfa May 9, 2026 0
Introduction: A Silent Crisis in Plain Sight In May 2023, U.S. Surgeon General Dr. Vivek Murthy issued...
Read More Read more about Beyond the Plate: How Shanti’s ‘Meals Heal’ Program is Confronting the Epidemic of Loneliness
The Resilience of Connection: Navigating Parental Illness Through Peer Support the-resilience-of-connection-navigating-parental-illness-through-peer-support
  • Patient Advocacy and Support

The Resilience of Connection: Navigating Parental Illness Through Peer Support

Neng Nana May 9, 2026 0
The diagnosis of a life-threatening illness does not merely affect the patient; it creates a seismic shift...
Read More Read more about The Resilience of Connection: Navigating Parental Illness Through Peer Support
Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence
  • Chemotherapy and Targeted Therapy

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Raul Delapena Setiawan May 9, 2026 0
In a significant milestone for the biotechnology industry, Odyssey Therapeutics has officially made its debut on the...
Read More Read more about Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Posts pagination

Previous 1 … 752 753 754 755 756 757 758 … 766 Next

Recent Posts

  • Unveiling Cancer’s Cunning Strategy: Oklahoma Research Exposes How Aggressive Breast Tumors Recruit Nerves to Fuel Growth
  • MacroGenics Initiates Phase I Trial for Promising Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors
  • Decoding the Connection: GLP-1 Medications and Breast Cancer Risk, Recurrence, and Treatment
  • A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness
  • A Landmark in Philanthropy: Karen and Rob Hale Commit $50 Million to the Breast Cancer Research Foundation

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unveiling-cancers-cunning-strategy-oklahoma-research-exposes-how-aggressive-breast-tumors-recruit-nerves-to-fuel-growth
  • Medical Research and Clinical Trials

Unveiling Cancer’s Cunning Strategy: Oklahoma Research Exposes How Aggressive Breast Tumors Recruit Nerves to Fuel Growth

Suro Senen October 16, 2026
macrogenics-initiates-phase-i-trial-for-promising-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors
  • Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Promising Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Iffa Jayyana October 16, 2026
decoding-the-connection-glp-1-medications-and-breast-cancer-risk-recurrence-and-treatment
  • Patient Advocacy and Support

Decoding the Connection: GLP-1 Medications and Breast Cancer Risk, Recurrence, and Treatment

Suro Senen October 16, 2026
a-global-beacon-of-hope-325-landmarks-to-illuminate-for-metastatic-breast-cancer-awareness-4
  • Patient Advocacy and Support

A Global Beacon of Hope: 325 Landmarks to Illuminate for Metastatic Breast Cancer Awareness

Asep Darmawan October 16, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.